Answers are grounded in this paper and cite their sources.
Investigates miR-148a-3p's role in inflammation in individuals with atopic dermatitis, suggesting its significant implications for disease management.
The study aims to investigate the expression characteristics and functions of miR-148a-3p in atopic dermatitis (AD), as well as its association with inflammation. A total of 150 skin tissue samples from patients with AD and 146 samples from healthy individuals were collected in this study. The expression level of miR-148a-3p was detected by RT-qPCR. An in vitro inflammatory model was established by treating HaCaT cells with TNF-α/IFN-γ. Cell proliferation and apoptosis were detected by the CCK-8 assay and flow cytometry, respectively. The levels of inflammatory factors were detected by ELISA and RT-qPCR. The targeting relationship between miR-148a-3p and PTEN was verified by dual-luciferase reporter assay. The expression of miR-148a-3p was significantly upregulated in the skin tissues of patients with AD and in TNF-α/IFN-γ-treated HaCaT cells. Inhibition of miR-148a-3p could promote cell proliferation, inhibit apoptosis, and significantly reduce the expression of inflammatory factors. PTEN was identified as a direct target of miR-148a-3p. Knockdown of PTEN reversed the protective effect of miR-148a-3p inhibitor on HaCaT cells. Under the context of AD, miR-148a-3p promotes the maintenance of inflammation and cell apoptosis in epidermal keratinocytes by inhibiting PTEN, which may exacerbate the disruption of the skin barrier.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: